Evidence map›Paper›PMID 42515765›Full record

ReviewPharmaceuticals (Basel, Switzerland)2026

Baseline PSMA PET/CT Biomarkers for Patient Selection in [

Grytė Galnaitienė, Matas Šimkus, Ieva Balčiūnaitė, Kornelija Lušaitė, Fang Wen, Marco Hoffmann, Matthias Saar, Felix M Mottaghy, Donatas Vajauskas, Susanne Lütje

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Grytė GalnaitienėDepartment of Radiology, Medical Academy, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.ORCID 0009-0009-8680-6470
Matas ŠimkusFaculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.
Ieva BalčiūnaitėDepartment of Radiology, Medical Academy, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.ORCID 0009-0000-2764-1834
Kornelija LušaitėDepartment of Radiology, Medical Academy, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.ORCID 0009-0003-1704-1669
Fang WenDepartment of Nuclear Medicine, University Hospital RWTH Aachen, 52074 Aachen, Germany.
Marco HoffmannDepartment Urology and Pediatric Urology, University Hospital RWTH Aachen, 52074 Aachen, Germany.
Matthias SaarDepartment Urology and Pediatric Urology, University Hospital RWTH Aachen, 52074 Aachen, Germany.ORCID 0000-0002-6351-8056
Felix M MottaghyDepartment of Nuclear Medicine, University Hospital RWTH Aachen, 52074 Aachen, Germany.ORCID 0000-0002-7212-6521
Donatas VajauskasDepartment of Radiology, Medical Academy, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.ORCID 0000-0002-3769-3520
Susanne LütjeDepartment of Nuclear Medicine, University Hospital RWTH Aachen, 52074 Aachen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PSMA PET/CT imaging biomarkers are increasingly investigated as predictors of response and survival outcomes following [

Indexed as

biomarkerspatient selectionPSMA PET/CTPSMA therapy

Identifiers

PMID42515765
PMCPMC13414503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.